Nashville, Tennessee — According to state and local development sources, Harrow plans to invest $3 Million to build out new space in Nashville. The company plans to occupy the new space at 102 Woodmont Blvd in Nashville, on or about April 1, 2025. According to the company website Harrow (NASDAQ: HROW) is a growing leader in the ophthalmic healthcare market. Our mission as a growing leader in the ophthalmic healthcare market is driven by two core values: (1) unyielding dedication to innovation and (2) a mission of providing affordable and accessible medications. We pride ourselves on closely listening to the needs of providers and their patients, so we can do everything in our power to address them with high-quality products and services. In addition, our mission is producing amazing financial results, making Harrow one of the fastest-growing ophthalmic pharmaceutical companies in the United States.

To learn more about Harrow, visit http://www.harrowinc.com/

Company Contact:
Mark Baum, Chief Executive Officer
844-446-6979

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.